Lung Cancer Surgery Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2025 – 2034
Report ID: GMI4076
Download Free PDF
Authors:
Monali Tayade,
Lung Cancer Surgery Market Size
The global lung cancer surgery market is on the cusp of substantial growth during 2025-2034, riding on impressive momentum witnessed in the year 2024. The market is driven by ongoing research and development processes focused on improving diagnostic equipment, surgical technology, and post-surgery care. With advances in early detection techniques and refinement in surgical technology, outcomes of lung cancer surgery are getting better in different populations. The inclusion of artificial intelligence (AI), machine learning (ML), and 3D preoperative planning has largely minimized surgical errors and risk to the patient, further making lung cancer surgery an essential part of oncologic treatment protocols.
The growing worldwide prevalence of lung cancer, fueled by demographics like aging populations, exposure to environmental toxins, and increased tobacco use in developing nations, has created an accelerated need for successful surgical procedures. Lung cancer kills about 340 individuals every day in the United States, the American Cancer Society estimates. Concurrently, the movement toward personalized medicine, fueled by genomics and biomarker profiling, is supporting more individualized surgical techniques. These advances are allowing thoracic surgeons to operate with increased accuracy, thereby enhancing survival and quality of life among those diagnosed in the early and moderate phases of lung cancer.
The lung cancer surgery market is also supported by higher public and private investment. Health authorities across the globe are providing huge budgets for cancer care facilities and early diagnosis programs. These investments, together with positive reimbursement policies in developed countries, are supporting the universal adoption of complex lung cancer surgical options.
Additionally, increased awareness campaigns regarding lung cancer screening and treatment through surgery are assisting in breaking the stigma related to invasive procedures. Comprehensive educational support is available now for patients, which promotes early testing and active treatment, both of which are crucial in enhancing the outcomes as well as fuelling market growth.
Lung Cancer Surgery Market Trends
One of the most impactful trends driving the market during 2025-2034 is the application of artificial intelligence (AI) and augmented reality (AR) in surgical planning and conduct. AI-based platforms aid surgeons in the radiological data analysis, marking tumor margins, and forecast patient-specific surgical complications. This trend is most applicable in minimally invasive procedures, where accuracy is critical.
Yet another trend in the offing is the increasing prominence of Ambulatory Surgical Centers (ASCs) for the treatment of lung cancer. With surgical methods becoming less and less invasive and recovery days shorter, procedures hitherto limited to hospitals are now done on an outpatient basis. ASCs provide cost savings, convenience, and reduced risk of hospital-acquired infections, making them a desirable choice for surgeries for early-stage lung cancer.
This movement is particularly evident in North America and regions of Europe, where healthcare systems are stressed to decrease costs without sacrificing the quality of care. The shift towards ASCs is facilitated by advancements in anesthesia, postoperative pain control, and ERAS protocols.
The extensive use of national lung cancer screening programs, especially through low-dose computed tomography (LDCT), is one of the strongest market drivers. Early detection via LDCT raises the chances of operable tumors being detected, thus raising the need for surgical treatment. Some nations like Japan, the US, and South Korea have already introduced similar programs, with many more joining the ranks.
Lung Cancer Surgery Market Analysis
The minimally invasive surgery (MIS) segment is expected to grow strongly by 2034 with the popularity of methods like video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS). These methods provide less trauma, less hospital stay, less postoperative pain, and quick recovery, making them a doctor and patient's first choice.
Technological innovations in surgical robotics, camera technology, and energy tools continue to enhance the safety and effectiveness of MIS solutions. Increased dexterity and precision, and better visualization quality, are increasing utilization in healthcare systems.
Furthermore, the surgical instrument segment should see significant growth in the demand for precision instruments that can navigate fine pulmonary structures. Specialized instruments used in the dissection of lung tissue, stapling, and sealing of vessels are becoming highly advanced, with ergonomic designs as well as smart feedback mechanisms.
By 2034, demand for disposable instruments will increase, led by infection control emphasis and single-use protocol adherence, particularly in outpatient and ambulatory settings.
Europe will experience a robust CAGR in the lung cancer surgery market for lung cancer surgery over the forecast period driven by a highly developed healthcare system, a growing geriatric population, and a rise in the incidence of lung cancer caused by environmental and lifestyle factors. Germany, France, and the UK are among the key countries investing heavily in early detection and surgical capacity, driving growth at the regional level.
While this, Asia-Pacific is becoming an attractive region because of growing healthcare investment, urbanization, and the prevalence of smoking. China and India are especially advancing their capabilities in thoracic surgery and raising awareness through national campaigns on health. These activities are driving profitable avenues for market players in search of geographical expansion.
Lung Cancer Surgery Market Share
Major players in the market for lung cancer surgery are:
These dominant competitors are actively working to expand their market position by investing in research and development, and partnerships. Intuitive Surgical and Ethicon are leaders in the robotic-assisted surgery sector with continual improvements of their products and FDA releases clearing state-of-the-art thoracic procedures.
Beyond that, organizations are globalizing through acquisitions, distribution agreements, and partnerships with local healthcare organizations. Training robotic and minimally invasive systems training for thoracic surgeons has become the standard practice, thereby assuring optimal use of advanced surgical equipment.
These firms' marketing efforts through physician outreach programs, patient education programs, and international oncology conferences are also promoting brand awareness and product uptake. Overall, these efforts place these firms at the center of lung cancer surgery's future.
Lung Cancer Surgery Industry News
In October 2023, the Food and Drug Administration approved Merck & Co.'s cancer treatment, Keytruda, for use before lung cancer surgery to reduce tumors and then afterward to prevent recurrence. Keytruda, the company said, is the first PD-1 inhibitor to be approved for both pre-and post-surgical use in lung cancer.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →